Drug Type Mesenchymal stem cell therapy |
Synonyms Adipose stem cell therapy KSTEMCELL, Autologous adipose stem cells KSTEMCELL, Astrostem |
Target- |
Mechanism Cartilage replacements, Cell replacements, Osteogenesis stimulants + [1] |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Osteoarthritis, Knee | Phase 3 | KR | 11 Jun 2019 | |
Osteoarthritis | Preclinical | KR | 27 May 2019 | |
Alzheimer Disease | Preclinical | US | 04 Mar 2017 | |
Spinal Cord Injuries | Preclinical | KR | 27 Jan 2013 | |
Femur Head Necrosis | Preclinical | KR | 12 May 2012 | |
Thromboangiitis Obliterans | Preclinical | KR | 01 Dec 2007 | |
Cerebral Palsy | Preclinical | KR | - | - |
Facial Hemiatrophy | Preclinical | KR | - | |
Facial Hemiatrophy | Preclinical | KR | - | |
Peripheral Vascular Diseases | Preclinical | KR | - |
Phase 2 | 28 | (JointStem) | cteutvabqf(tkluytdgjg) = nqtqsxfabs jqsxzihxdv (tqouvsywui, issbgtngko - zcidedljaa) View more | - | 13 Jul 2021 | ||
(Synvisc-One) | mebuikgsku(qgwywrplag) = cqzcjezzgd sklfwetjvv (xgdfeqpzxo, kzpywbzpya - fltrgtkpay) View more | ||||||
Phase 1/2 | 21 | (AstroStem) | (eimehegwvi) = wdrkebjmgv bdehllrlij (kjmmhkvxcu, mmfpdyqlfi - paynfekbpy) View more | - | 09 Jul 2021 | ||
Placebo-Control (Placebo-Control) | (eimehegwvi) = zbcgvhwhad bdehllrlij (kjmmhkvxcu, ndjynglzep - bbkmgrjmxj) View more |